IL-10-Engineered Human CD4⁺ Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism

Main text

(Molecular Therapy 25, 2254–2269; October 2017)

In the originally published version of this article, there is an error in Figure 8A, where there is a duplication of the mouse pictures at day 5 and day 7. The error occurred during the editing of Figure 8A and does not affect the overall conclusion of the paper. A corrected version of the figure is provided below.

The authors apologize for this error and any confusion this may have caused.

Figure 8. CD4^IL-10 Cells Contribute with Allogeneic PBMCs in Mediating GvL while Inhibiting XenoGvHD